[5-hydroxy-4-(hydroxymethyl)-6-methyl-3-pyridyl]methyl nicotinate
Basic Information
- CAS No.: 15871-78-0
Physical properties
Product Description
Export Top Purity [5-hydroxy-4-(hydroxymethyl)-6-methyl-3-pyridyl]methyl nicotinate 15871-78-0 In Stock
- Molecular Formula: C14H14 N2 O4
- Molecular Weight: 274.276
- Vapor Pressure: 5.56E-13mmHg at 25°C
- Boiling Point: 551.1°Cat760mmHg
- PKA: 9.42±0.10(Predicted)
- Flash Point: 287.1°C
- PSA: 92.54000
- Density: 1.351g/cm3
- LogP: 1.33990
[5-hydroxy-4-(hydroxymethyl)-6-methyl-3-pyridyl]methyl nicotinate(Cas 15871-78-0) Usage
|
General Description |
[5-hydroxy-4-(hydroxymethyl)-6-methyl-3-pyridyl]methyl nicotinate is a chemical compound with potential therapeutic effects. It is a derivative of nicotinic acid, also known as niacin or vitamin B3. [5-hydroxy-4-(hydroxymethyl)-6-methyl-3-pyridyl]methyl nicotinate has been studied for its potential benefits in improving blood circulation and functioning as a vasodilator, which can help in the treatment of cardiovascular diseases and other conditions related to blood flow. It is also being researched for its potential roles in reducing inflammation and oxidative stress, which could have implications for conditions such as arthritis and neurodegenerative diseases. Studies on this compound continue to investigate its potential therapeutic applications and safety profile. |
InChI:InChI=1/C14H14N2O4/c1-9-13(18)12(7-17)11(6-16-9)8-20-14(19)10-3-2-4-15-5-10/h2-6,17-18H,7-8H2,1H3
15871-78-0 Process route
-
-
15871-78-0
[5-hydroxy-4-(hydroxymethyl)-6-methyl-3-pyridyl]methyl nicotinate
| Conditions | Yield |
|---|---|
|
Aus 3,4-O-Isopropylidenpyridoxin und Nicotinsaeure-di-cyclohexylcarbodiimid;
|
|
|
Aus 2-Me-3-HO-4-HOCH2-5-ClCH2-pyridin und K-Nicotinat;
|
|
|
Beim Erwaermen von 3,α4-O-Isopropyliden-α5-O-nicotinoyl-pyridoxin in wss. HCl;
|
|
|
α4,3-O-Isopropyliden-α5-O-nicotinoylpyridoxin, HBr/A.;
|
|
|
Aus α4,5-O-Isopropylidenpyridoxin-α3-nicotinat (I) mit EtOH/HBr;
|
|
|
entspr. Vitamin-B6-Verb., Acyl.;
|
|
|
Isopropylidenderivat II, HBr, A./W.;
|